BDD 2020 Online - Posters | Royal Belgian Society of Dermatology and Venerology

Poster 1

Efficacy and Safety of Baricitinib in Moderate to Severe Atopic Dermatitis: Results of Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-week Trials (BREEZE-AD1 and BREEZE-AD2.

View the poster more closely

Efficacy and Safety of Baricitinib in Moderate to Severe Atopic Dermatitis: Results of Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-week Trials (BREEZE-AD1 and BREEZE-AD2.

Poster 2

Rapid and Concurrent Improvements in Signs and Symptoms of Atopic Dermatitis with Baricitinib in Phase 3 Studies.

View the poster more closely

Rapid and Concurrent Improvements in Signs and Symptoms of Atopic Dermatitis with Baricitinib in Phase 3 Studies.

Poster 3

A Belgian Consensus On The Definition Of A Treat-To-Target Outcome Set In Psoriasis Management.

View the poster more closely

A Belgian Consensus On The Definition Of A Treat-To-Target Outcome Set In Psoriasis Management.

Poster 4

Novel mutation in the ichthyin gene erroneously diagnosed and treated as ‘Ichthyosis vulgaris’ and ‘Psoriasis’.

Listen to the author

Novel mutation in the ichthyin gene erroneously diagnosed and treated as ‘Ichthyosis vulgaris’ and ‘Psoriasis’.

View the poster more closely

Novel mutation in the ichthyin gene erroneously diagnosed and treated as ‘Ichthyosis vulgaris’ and ‘Psoriasis’.

Poster 5

The many faces of granulomatous facial eruptions: a case report of granulomatous acne rosacea.

View the poster more closely

The many faces of granulomatous facial eruptions: a case report of granulomatous acne rosacea.

Poster 6

Secondary resistance to Vismodegib through acquired pathogenic SMO mutations: a case series.

Listen to the author

Secondary resistance to Vismodegib through acquired pathogenic SMO mutations: a case series.

Poster 7

Skin parameter maps in multispectral dermoscopy.

Listen to the author

Skin parameter maps in multispectral dermoscopy.

View the poster more closely

Secondary resistance to Vismodegib through acquired pathogenic SMO mutations: a case series.

Poster 8

Utility of patch testing for the diagnosis of delayed-type hypersensitivity reactions to clindamycin.

Listen to the author

Utility of patch testing for the diagnosis of delayed-type hypersensitivity reactions to clindamycin.

View the poster more closely

Utility of patch testing for the diagnosis of delayed-type hypersensitivity reactions to clindamycin.

Poster 9

Diagnostic approach to harlequin syndrome: a case report.

Listen to the author

Diagnostic approach to harlequin syndrome: a case report.

View the poster more closely

Diagnostic approach to harlequin syndrome: a case report.

Poster 10

Myth, belief and dogmatic thinking moves into hair science and technology during our XXIst century.

View the poster more closely

Myth, belief and dogmatic thinking moves into hair science and technology during our XXIst century.

Poster 11

Secukinumab sustainability: The Belgian Experience.

View the poster more closely

Secukinumab sustainability: The Belgian Experience.

Poster 12

Acral pigmented lesions: do dermoscopy!

Listen to the author

Acral pigmented lesions: do dermoscopy!

View the poster more closely

Acral pigmented lesions: do dermoscopy!

Poster 13

Inspect the skin, but don’t forget the brain: a case of Giant Congenital Melanocytic Nevus in a newborn.

Listen to the author

Inspect the skin, but don’t forget the brain: a case of Giant Congenital Melanocytic Nevus in a newborn.

View the poster more closely

Inspect the skin, but don’t forget the brain: a case of Giant Congenital Melanocytic Nevus in a newborn.

Poster 14

Optimizing skin cancer detection in the general population: an early access lesion-directed consultation.

View the poster more closely.

Optimizing skin cancer detection in the general population: an early access lesion-directed consultation.

Poster 15

Nailfold videocapillaroscopy: a diagnostic tool when clinical evaluation is misleading.

View the poster more closely

Nailfold videocapillaroscopy: a diagnostic tool when clinical evaluation is misleading.

Poster 16

Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis.

View the poster more closely

Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis.

Poster 17

A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 12-Week Efficacy, Safety, and Speed of Response from a Randomized, Double-Blinded Trial.